Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a

Medpace Holdings, Inc. (MEDP) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Medpace Holdings, Inc. (MEDP) trades at a P/E ratio of 34.6×. Over the past ten years it has ranged from 0.0× (September 2016) to 96.2× (December 2016); the current reading is higher than 58% of that period. That is in line with the Diagnostics & Research industry median of 34.5× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 35.9× 40.99%
FY2024 25.4× (23.42%)
FY2023 33.2× 21.36%
FY2022 27.4× (36.37%)
FY2021 43.0× 25.76%
FY2020 34.2× 13.52%
FY2019 30.1× 19.54%
FY2018 25.2× (32.14%)
FY2017 37.1× (58.87%)
FY2016 90.3× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 34.0× 11.63%
Jun 2026 30.5× 2.99%
Mar 2026 29.6× (17.56%)
Dec 2025 35.9× 2.26%
40 more quarters

Against its own ten years

Low 0.0× High 96.2×
Ten-year median 32.7×
Current reading's percentile 58

P/E ratio against peers

Company P/E ratio
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 25.0×
QGEN QIAGEN N.V. compare 26.1×
LH Labcorp Holdings Inc. compare 29.5×
ICLR ICON PLC compare 34.5×
MEDP Medpace Holdings, Inc. 34.6×
ILMN Illumina, Inc. compare 35.6×
RVTY Revvity Inc. compare 71.9×
CRL Charles River Laboratories International, Inc. compare 300×
Diagnostics & Research industry median 34.5×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MEDP